InnoCare Pharma Ltd. (9969) Financial Statements

2 Followers

InnoCare Pharma Ltd. Financial Overview

InnoCare Pharma Ltd.'s market cap is currently HK$22.49B. The company's EPS TTM is HK$0.4358083048; its P/E ratio is 31.11; InnoCare Pharma Ltd. is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 2.30B	¥ 1.01B	¥ 738.54M	¥ 625.40M	¥ 1.04B
Gross Profit	¥ 2.01B	¥ 871.01M	¥ 610.10M	¥ 482.01M	¥ 977.37M
Operating Income	¥ 440.59M	¥ -525.78M	¥ -651.15M	¥ -770.40M	¥ -181.10M
EBITDA	¥ 555.89M	¥ -463.49M	¥ -516.55M	¥ -808.28M	¥ 16.23M
Net Income	¥ 625.84M	¥ -440.63M	¥ -631.26M	¥ -886.59M	¥ -64.55M
Balance Sheet
Cash & Short-Term Investments	¥ 7.34B	¥ 6.22B	¥ 8.22B	¥ 9.01B	¥ 6.25B
Total Assets	¥ 10.83B	¥ 9.41B	¥ 9.92B	¥ 10.32B	¥ 7.40B
Total Debt	¥ 1.61B	¥ 1.27B	¥ 1.35B	¥ 1.25B	¥ 1.27B
Net Debt	¥ -5.46B	¥ -4.95B	¥ -6.88B	¥ -7.45B	¥ -4.66B
Total Liabilities	¥ 2.79B	¥ 2.66B	¥ 2.74B	¥ 2.68B	¥ 1.74B
Stockholders' Equity	¥ 7.73B	¥ 6.73B	¥ 7.15B	¥ 7.60B	¥ 5.60B
Cash Flow
Free Cash Flow	¥ 130.80M	¥ -443.78M	¥ -926.00M	¥ -935.88M	¥ -11.00K
Operating Cash Flow	¥ 199.15M	¥ -365.55M	¥ -671.34M	¥ -565.55M	¥ 167.06M
Investing Cash Flow	¥ -358.03M	¥ 1.11B	¥ 666.91M	¥ -1.73B	¥ -1.73B
Financing Cash Flow	¥ -32.84M	¥ -285.60M	¥ 1.31M	¥ 3.09B	¥ 2.54B

Currency in CNY

InnoCare Pharma Ltd. Earnings and Revenue History

Income Statement >

InnoCare Pharma Ltd. Debt to Assets

Balance Sheet >

InnoCare Pharma Ltd. Cash Flow

Cash Flow >

InnoCare Pharma Ltd. Forecast EPS vs Actual EPS

Earnings >